John D. Sinden

A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke.

ReNeuron Group plc.

Differential development of neuronal physiological responsiveness in two human neural stem cell lines.

Implantation of c-mycER TAM immortalized human mesencephalic-derived clonal cell lines ameliorates behavior dysfunction in a rat model of Parkinson's disease.

Methodological study investigating long term laser Doppler measured cerebral blood flow changes in a permanently occluded rat stroke model.

Increased neuronal proliferation in the dentate gyrus of aged rats following neural stem cell implantation.

c-MycERTAM transgene silencing in a genetically modified human neural stem cell line implanted into MCAo rodent brain.

Stem cell treatment of ischemic brain injury.

Immortalized human fetal retinal cells retain progenitor characteristics and represent a potential source for the treatment of retinal degenerative disease.

Implantation site and lesion topology determine efficacy of a human neural stem cell line in a rat model of chronic stroke.

Stem cells in stroke treatment: the promise and the challenges.

In vivo and in vitro characterization of the angiogenic effect of CTX0E03 human neural stem cells.

Prospects for stem cell-derived therapy in stroke.

The effects of microRNAs on human neural stem cell differentiation in two- and three-dimensional cultures.

In vitro modeling of the neurovascular environment by coculturing adult human brain endothelial cells with human neural stem cells.